From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting
Maria Gloria Mumolo, Linda Ceccarelli, Giorgia Di Fluri, Francesco Costa, Department of General Surgery and Gastroenterology, Gastroenterology Unit, Azienda Ospedaliero Universitaria Pisana, Pisa 56124, Italy
Lorenzo Bertani, Gabriella Laino, Eleonora Albano, Gherardo Tapete, Department of New Technologies and Translational Research in Medicine and Surgery, University of Pisa, Pisa 56122, Italy
Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and final approval of the final version.
Conflict-of-interest statement: The authors have declared that no potential conflict of interest exists.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Francesco Costa, MD, PhD, Chief Doctor, Gastroenterology Unit, Azienda Ospedaliero Universitaria Pisana, via Paradisa 2, Pisa 56124, Italy. email@example.com
Telephone: +39-050997392 Fax: +39-050997392
Received: May 4, 2018
Peer-review started: May 5, 2018
First decision: May 17, 2018
Revised: June 5, 2018
Accepted: June 27, 2018
Article in press: June 27, 2018
Published online: September 7, 2018